These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacodynamics in older adults: a review. Bowie MW; Slattum PW Am J Geriatr Pharmacother; 2007 Sep; 5(3):263-303. PubMed ID: 17996666 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic crisis in the elderly. ElDesoky ES Am J Ther; 2007; 14(5):488-98. PubMed ID: 17890940 [TBL] [Abstract][Full Text] [Related]
4. Geriatric pharmacology for the dentist. An overview. Picozzi A; Neidle EA Dent Clin North Am; 1984 Jul; 28(3):581-93. PubMed ID: 6589185 [TBL] [Abstract][Full Text] [Related]
5. Drugs and the elderly patient. Bsoul SA; Terezhalmy G Gen Dent; 2007; 55(3):238-43; quiz 244, 264. PubMed ID: 17511370 [TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic basis for altered drug action in the elderly. Roberts J; Tumer N Clin Geriatr Med; 1988 Feb; 4(1):127-49. PubMed ID: 3278786 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic monitoring of the elderly in critical care. Planchock NY; Slay LE Crit Care Nurs Clin North Am; 1996 Mar; 8(1):79-89. PubMed ID: 8695038 [TBL] [Abstract][Full Text] [Related]
8. Altered pharmacodynamics in the elderly. Feely J; Coakley D Clin Geriatr Med; 1990 May; 6(2):269-83. PubMed ID: 2184923 [TBL] [Abstract][Full Text] [Related]
9. Age and the endocrine system. Noth RH; Mazzaferri EL Clin Geriatr Med; 1985 Feb; 1(1):223-50. PubMed ID: 3913501 [TBL] [Abstract][Full Text] [Related]
11. Bridging the gap: ageing, pharmacokinetics and pharmacodynamics. Burton DG; Allen MC; Bird JL; Faragher RG J Pharm Pharmacol; 2005 Jun; 57(6):671-9. PubMed ID: 15969921 [TBL] [Abstract][Full Text] [Related]
12. Age-related changes of neuro-endocrine-immune interactions in healthy humans. Mazzoccoli G; Correra M; Bianco G; De Cata A; Balzanelli M; Giuliani A; Tarquini R J Biol Regul Homeost Agents; 1997; 11(4):143-7. PubMed ID: 9582614 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacodynamic changes in the elderly subject]. Beltrami G; Menegolli G; Bellamoli C; Grezzana L; Zavateri G Clin Ter; 1996 Apr; 147(4):181-91. PubMed ID: 8766350 [TBL] [Abstract][Full Text] [Related]
14. Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs. Gidal BE Epilepsy Res; 2006 Jan; 68 Suppl 1():S65-9. PubMed ID: 16413756 [TBL] [Abstract][Full Text] [Related]
15. Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs. Reife RA Adv Neurol; 1998; 76():95-103. PubMed ID: 9408466 [TBL] [Abstract][Full Text] [Related]
16. Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy. Lamy PP Drugs Aging; 1991; 1(5):385-404. PubMed ID: 1665372 [TBL] [Abstract][Full Text] [Related]
17. Drug therapy in the elderly. Turnheim K Exp Gerontol; 2004; 39(11-12):1731-8. PubMed ID: 15582289 [TBL] [Abstract][Full Text] [Related]
19. Recent pharmacologic advances in antidepressant therapy for the elderly. Preskorn SH Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477 [TBL] [Abstract][Full Text] [Related]